Satellos Bioscience Inc. (MSLE)
NASDAQ: MSLE · Real-Time Price · USD
8.50
-0.31 (-3.52%)
Sep 29, 2026, 11:11 AM EDT - Market open
Satellos Bioscience Market Cap
Satellos Bioscience has a market cap or net worth of $186.53 million as of September 29, 2026. Its market cap has increased by 112.90% in one year.
Market Cap
186.53M
Enterprise Value
124.54M
1-Year Change
112.90%
Ranking
Category
Stock Price
$8.50
ChartMarket Cap Chart
Since August 19, 2021, Satellos Bioscience's market cap has increased from $45.99M to $186.53M, an increase of 305.56%. That is a compound annual growth rate of 31.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 186.53M | 108.89% |
| Dec 31, 2025 | 89.30M | -6.65% |
| Dec 31, 2024 | 95.65M | 160.46% |
| Dec 29, 2023 | 36.73M | 440.53% |
| Dec 30, 2022 | 6.79M | -73.94% |
| Dec 31, 2021 | 26.07M | -43.31% |
| Aug 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veraxa Biotech AG | 199.39M |
| Nkarta | 196.97M |
| Oramed Pharmaceuticals | 196.76M |
| Adagene | 196.73M |
| Protara Therapeutics | 193.83M |
| Alpha Cognition | 184.46M |
| AN2 Therapeutics | 184.15M |
| ALX Oncology Holdings | 181.14M |